Metraipolis › archive › dc_e44da2888a4e

Pharmacoeconomic evaluation of ICS-LABA therapy in pediatric asthma: a cost-effectiveness and cost-utility analysis — Europe PMC PMID:41104341

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41104341
DOI
10.3389/fphar.2025.1639444
License (as archived)
solo-consultazione
Archived
2026-11-09T15:52:38.154Z
SHA-256 of the archived text
04587985d8fc1321c52542c4158f876c15010e985662594bebc6ff3361c53271
Stable URL of this page
https://metraipolis.com/documento/dc_e44da2888a4e

How to cite

Pharmacoeconomic evaluation of ICS-LABA therapy in pediatric asthma: a cost-effectiveness and cost-utility analysis — Europe PMC PMID:41104341 — Europe PMC (en), https://europepmc.org/article/MED/41104341 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e44da2888a4e (Metraipolis archive dc_e44da2888a4e, sha256 04587985d8fc1321c52542c4158f876c15010e985662594bebc6ff3361c53271)
BibTeX
@misc{dce44da2888a4e,
  title = {Pharmacoeconomic evaluation of ICS-LABA therapy in pediatric asthma: a cost-effectiveness and cost-utility analysis — Europe PMC PMID:41104341},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41104341},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e44da2888a4e; sha256 04587985d8fc1321c52542c4158f876c15010e985662594bebc6ff3361c53271},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41104341. Agents can read the archived copy with the MCP tool read_document.